Lidocaine hydrochloride
USP/1366013 - United States Pharmacopeia (USP) Reference Standard
Synonym: Lidocaine hydrochloride monohydrate; 2-
CAS Number: 6108-05-0
Empirical Formula (Hill Notation): C14H22N2O · HCl · H2O
Molecular Weight: 288.81
MDL Number: MFCD00150329
Linear Formula: C14H22N2O · HCl · H2O
Product Type: Chemical
| API family | lidocaine |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C14H22N2O.ClH.H2O/c1-5 |
| InChI key | YECIFGHRMFEPJK-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | Cl[H].[H]O[H].CCN(CC)CC(= |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Lidocaine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Lidocaine, Racepinephrine, and Tetracaine Hydrochlorides Compounded Topical Gel |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| Other Notes: | Sales restrictions may apply. |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |


